作者：
Lee, Hans C. [1]
;
Raje, Noopur S. [2]
;
Landgren, Ola [3]
;
Upreti, Vijay V. [4]
;
Wang, Jin [5]
;
Avilion, Ariel A. [6]
;
Hu, Xuguang [7]
;
Rasmussen, Erik [8]
;
Ngarmchamnanrith, Gataree [9]
;
Fujii, Hisaki [10]
;
Spencer, Andrew
作者单位：
Amgen Inc, Clin Dev, Thousand Oaks, CA 91320 USA
[1]
Harvard Med Sch, Ctr Multiple Myeloma, Massachusetts Gen Hosp, Boston, MA 02115 USA
[2]
Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, New York, NY 10021 USA
[3]
Amgen Inc, Clin Biomarkers & Diagnost, San Francisco, CA USA
[4]
Amgen Inc, Translat Med, San Francisco, CA USA
[5]
Amgen Inc, Bioanalyt Sci, Thousand Oaks, CA 91320 USA
[6]
Monash Univ, Alfred Hosp, Malignant Haematol & Stem Cell Transplantat Serv, Melbourne, Vic
[7]
Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
[8]
Amgen Inc, Clin Pharmacol Modeling & Simulat, San Francisco, CA USA
[9]
Amgen Inc, Global Biostat Sci, Thousand Oaks, CA 91320 USA
[10]
发布时间
2021-07-24
换一批
换一批
